| Name | Walgreens #12509 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 700 30th Ave S, Moorhead, Minnesota 56560 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (218) 331-2668 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The drug acalabrutinib, FDA-approved for the treatment of several types of B cell cancers, improved the oxygenation levels and decreased molecular markers of inflammation in a majority of 19 patients hospitalized for the treatment of severe COVID-19, according to a new study by Mark Roschewski and colleagues.
Affymax, Inc. today announced that it has received a $10 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize peginesatide (formerly known as Hematide™), Affymax's investigational drug for the treatment of anemia in chronic renal failure patients.
For years, obtaining parental consent for clinical research regarding newborn resuscitation in the delivery room has been a challenge. Now, a Saint Louis University pediatric researcher is asking new mothers and pregnant women when doctors should seek parental permission to allow medical research related to delivery room treatments.
Collated Childhood cancer statistics in sub-Saharan Africa have been published for the first time as a monograph in the peer reviewed journal ecancermedicalscience, allowing researchers and policymakers a critical new insight into the impact of pediatric cancer across this region.
› Verified 1 days ago
| NPI Number | 1235469826 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #12509 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 700 30th Ave S, Moorhead, MN 56560 |
| Phone Number | 218-331-2668 |
News Archive
The drug acalabrutinib, FDA-approved for the treatment of several types of B cell cancers, improved the oxygenation levels and decreased molecular markers of inflammation in a majority of 19 patients hospitalized for the treatment of severe COVID-19, according to a new study by Mark Roschewski and colleagues.
Affymax, Inc. today announced that it has received a $10 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize peginesatide (formerly known as Hematide™), Affymax's investigational drug for the treatment of anemia in chronic renal failure patients.
For years, obtaining parental consent for clinical research regarding newborn resuscitation in the delivery room has been a challenge. Now, a Saint Louis University pediatric researcher is asking new mothers and pregnant women when doctors should seek parental permission to allow medical research related to delivery room treatments.
Collated Childhood cancer statistics in sub-Saharan Africa have been published for the first time as a monograph in the peer reviewed journal ecancermedicalscience, allowing researchers and policymakers a critical new insight into the impact of pediatric cancer across this region.
› Verified 1 days ago
News Archive
The drug acalabrutinib, FDA-approved for the treatment of several types of B cell cancers, improved the oxygenation levels and decreased molecular markers of inflammation in a majority of 19 patients hospitalized for the treatment of severe COVID-19, according to a new study by Mark Roschewski and colleagues.
Affymax, Inc. today announced that it has received a $10 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize peginesatide (formerly known as Hematide™), Affymax's investigational drug for the treatment of anemia in chronic renal failure patients.
For years, obtaining parental consent for clinical research regarding newborn resuscitation in the delivery room has been a challenge. Now, a Saint Louis University pediatric researcher is asking new mothers and pregnant women when doctors should seek parental permission to allow medical research related to delivery room treatments.
Collated Childhood cancer statistics in sub-Saharan Africa have been published for the first time as a monograph in the peer reviewed journal ecancermedicalscience, allowing researchers and policymakers a critical new insight into the impact of pediatric cancer across this region.
› Verified 1 days ago
Cvs Pharmacy #08527 Type: Medicare Supplier Location: 822 30th Ave S, Moorhead, Minnesota 56560 Phone: (218) 236-0807 | |
Cvs Pharmacy #16185 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3301 Highway 10 E, Moorhead, Minnesota 56560 Phone: (218) 233-2953 | |
Sanford Pharmacy Moorhead Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4000 28th S Ave, Moorhead, Minnesota 56560 Phone: (701) 234-3250 | |
Walgreens #10187 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 900 Main Ave, Moorhead, Minnesota 56560 Phone: (218) 236-0252 | |
Cash Wise Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3300 Highway 10 E, Moorhead, Minnesota 56560 Phone: (218) 236-0345 |